Your browser doesn't support javascript.
loading
Ciprofloxacin in critically ill subjects: considering hepatic function, age and sex to choose the optimal dose.
Li, Xia; Zoller, Michael; Fuhr, Uwe; Huseyn-Zada, Mikayil; Maier, Barbara; Vogeser, Michael; Zander, Johannes; Taubert, Max.
Afiliação
  • Li X; Department I of Pharmacology, Clinical Pharmacology, Cologne University Hospital, Cologne, Germany.
  • Zoller M; Department of Anesthesiology, Hospital of the Ludwig-Maximilians-University of Munich, Munich, Germany.
  • Fuhr U; Department I of Pharmacology, Clinical Pharmacology, Cologne University Hospital, Cologne, Germany.
  • Huseyn-Zada M; Department of Anesthesiology, Hospital of the Ludwig-Maximilians-University of Munich, Munich, Germany.
  • Maier B; Institute of Laboratory Medicine, Hospital of the Ludwig-Maximilians-University of Munich, Munich, Germany.
  • Vogeser M; Institute of Laboratory Medicine, Hospital of the Ludwig-Maximilians-University of Munich, Munich, Germany.
  • Zander J; Institute of Laboratory Medicine, Hospital of the Ludwig-Maximilians-University of Munich, Munich, Germany.
  • Taubert M; Department I of Pharmacology, Clinical Pharmacology, Cologne University Hospital, Cologne, Germany.
J Antimicrob Chemother ; 74(3): 682-690, 2019 03 01.
Article em En | MEDLINE | ID: mdl-30500905

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ciprofloxacina / Estado Terminal / Antibacterianos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ciprofloxacina / Estado Terminal / Antibacterianos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article